An NCI-designated Comprehensive Cancer Center

Christine Brown, Ph.D.

The Heritage Provider Network Professor in Immunotherapy
Research Focus
  • Chimeric Antigen Receptor (CAR) T cell therapy for cancer, with particular focus on its application to brain tumors
  • Brain tumor immunology
  • Glioma cancer stem cells
Deputy Director, T Cell Therapeutics Research Laboratory; Associate Research Professor, Departments of Hematology & Hematopoietic Cell Transplantation and Immuno-Oncology

Research Teams

Dr. Christine Brown is a faculty member in the Departments of Hematology & Hematopoietic Cell Transplantation and Immuno-Oncology.

As deputy director of the T Cell Therapeutics Research Laboratory, Brown, the Heritage Provider Network Professor in Immunotherapy, provides scientific oversight for the preclinical research program, as well as the ongoing clinical trial program focused on the development of CAR-engineered T cells for the treatment of hematological malignancies and solid tumors. Dr. Brown’s personal research efforts are focused on developing and refining redirected CAR T cells for the treatment of malignant brain tumors.

Dr. Brown received her doctoral degree from the University of California Berkeley, and was a Leukemia & Lymphoma Scholar during her postdoctoral fellowship at Pennsylvania State University. Her scientific contributions to the development and optimization of tumor-specific CAR T cells for the treatment of glioblastoma are supported by the California Institute for Regenerative Medicine and are the basis of an ongoing phase I clinical trial which is supported by Gateway for Cancer Research and R01 FD005129.


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

Information listed here is obtained from Pubmed, a public database; City of Hope is not responsible for its accuracy. View all publications.

In The News
An Expert's Voice
Feldman and Badie Thumbnail

Rescue Mission

Scorpion Venom for Brain Cancer | City of Hope

From scorpion to immunotherapy: City of Hope scientists repurpose nature’s toxin for first-of-its kind CAR T cell therapy to treat brain tumors

brain tumor

New immunotherapy trial targets recurrent glioblastoma